0000904454-16-001207.txt : 20160510 0000904454-16-001207.hdr.sgml : 20160510 20160510172012 ACCESSION NUMBER: 0000904454-16-001207 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160510 DATE AS OF CHANGE: 20160510 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics AG CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: C4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-89113 FILM NUMBER: 161636919 BUSINESS ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 BUSINESS PHONE: 43 (0)1 740 93-0 MAIL ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST CENTRAL INDEX KEY: 0001026720 IRS NUMBER: 986038021 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 215 EUSTON ROAD CITY: LONDON STATE: X0 ZIP: NW1 2BE BUSINESS PHONE: 011 44 20 7611 8888 MAIL ADDRESS: STREET 1: 215 EUSTON ROAD CITY: LONDON STATE: X0 ZIP: NW1 2BE FORMER COMPANY: FORMER CONFORMED NAME: WELLCOME TRUST LTD DATE OF NAME CHANGE: 19961108 SC 13G/A 1 s13ga_050616-nabriva.htm SCHEDULE 13G/A FOR NABRIVA THERAPEUTICS AG BY THE WELLCOME TRUST LIMITED Unassociated Document
 
 

 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13G
RULE 13d-2
 
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS
THERETO FILED PURSUANT TO
(Amendment No. 1)*
 
 
Nabriva Therapeutics AG
(Name of Issuer)
 
Common Shares, nominal value €1.00 per share
(Title of Class of Securities)
 
62957M104** 
(CUSIP Number)
 
April 19, 2016
(Date of Event Which Requires Filing of this Statement)

 
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
[   ] Rule 13d-1(b)
 
[X] Rule 13d-1(c)
 
[   ] Rule 13d-1(d)
 
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
**This CUSIP number is assigned to the Issuer’s American Depositary Shares, each representing one-tenth (1/10) of a Common Share.
 
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
 

 
 
 
 


CUSIP No. 62957M104
 

  1
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
The Wellcome Trust Limited as trustee of the Wellcome Trust
 
  2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  [   ]
(b)  [   ]
 
  3
SEC USE ONLY
 
 
  4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United Kingdom
 
NUMBER OF
SHARES
 BENEFICIALLY 
OWNED BY
EACH
REPORTING
PERSON
WITH:
5
SOLE VOTING POWER
 
1,354
 
6
SHARED VOTING POWER
 
 
7
SOLE DISPOSITIVE POWER
 
1,354
 
8
SHARED DISPOSITIVE POWER
 
 
  9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,354
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)   [   ]
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
0.064%
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
FI
 
 
 

 

 
2
 

 
CUSIP No. 62957M104

 

Item 1(a).
Name of Issuer:
 
  
 
Nabriva Therapeutics AG (the “Issuer”)
 
  
Item 1(b).
Address of Issuer’s Principal Executive Offices:
 
  
 
Leberstrasse 20, 1110 Vienna, Austria
 
  
Item 2(a).
Name of Persons Filing:
 
  
 
The Wellcome Trust Limited as trustee of the Wellcome Trust
 
  
Item 2(b).
Address of Principal Business Office or, if None, Residence:
 
  
 
215 Euston Road, London NW1 2BE, United Kingdom
 
  
Item 2(c).
Citizenship:
 
  
 
United Kingdom
 
  
Item 2(d).
Title of Class of Securities:
 
  
 
Common Shares, nominal value €1.00 per share
 
  
Item 2(e).
CUSIP Number:
 
  
 
62957M104.  This CUSIP number is assigned to the Issuer’s American Depositary Shares, each representing one-tenth (1/10) of a Common Share.
 
  
Item 3.
If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
 
(a)
[   ]
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
(b)
[   ]
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c)
[   ]
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
(d)
[   ]
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e)
[   ]
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
(f)
[   ]
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
(g)
[   ]
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
(h)
[   ]
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
[   ]
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
[   ]
Group, in accordance with §240.13d-1(b)(1)(ii)(J).
 
 

 

 
3
 

 
CUSIP No. 62957M104
 
Item 4.
Ownership.
 
The information in items 1 and 5 through 11 on the cover page (p. 2) of this Schedule 13G is hereby incorporated by reference.
 
Item 5.
Ownership of Five Percent or Less of a Class.
 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X].
 
Item 6.
Ownership of More than Five Percent on Behalf of Another Person.
 
Not applicable.
 
Item 7.
Identification and Classification of the Subsidiary which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
 
Not applicable.
 
Item 8.
Identification and Classification of Members of the Group.
 
Not applicable.
 
Item 9.
Notice of Dissolution of Group.
 
Not applicable.
 
Item 10.
Certification.
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a–11.
 
 

 

 
4
 

 
CUSIP No. 62957M104
 
SIGNATURES
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


 
The Wellcome Trust Limited
as trustee of the Wellcome Trust
 
   
Dated:  May 6, 2016
/s/ Peter Pereira Gray
 
Name:
   Peter Pereira Gray
 
Title:
   Managing Director, Investment Division
 
 
 

 
 
5